Show simple item record

Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine

dc.contributor.authorBlue, Thomas R.
dc.contributor.authorGordon, Michael S.
dc.contributor.authorSchwartz, Robert P.
dc.contributor.authorCouvillion, Kathryn
dc.contributor.authorVocci, Frank J.
dc.contributor.authorFitzgerald, Terrence T.
dc.contributor.authorO’Grady, Kevin E.
dc.date.accessioned2021-06-04T16:32:28Z
dc.date.available2021-06-04T16:32:28Z
dc.date.issued2019-12-02
dc.identifierhttps://doi.org/10.13016/sduk-cwdh
dc.identifier.citationBlue, T.R., Gordon, M.S., Schwartz, R.P. et al. Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine. Addict Sci Clin Pract 14, 45 (2019).en_US
dc.identifier.urihttp://hdl.handle.net/1903/27109
dc.description.abstractIt has been estimated that approximately 15% of people who are incarcerated in the US have histories of opioid use disorder. Relapse to opioid use after release from prison poses a serious risk of HIV infection. Prison-initiated buprenorphine may help to reduce HIV infection given the association between opioid use and HIV-risk behaviors.en_US
dc.description.urihttps://doi.org/10.1186/s13722-019-0172-2
dc.language.isoen_USen_US
dc.publisherSpringer Natureen_US
dc.subjectHiv-risk behavioren_US
dc.subjectBuprenorphineen_US
dc.subjectPrisonen_US
dc.subjectOpioid use disorderen_US
dc.subjectCorrectional settingsen_US
dc.titleLongitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphineen_US
dc.typeArticleen_US
dc.relation.isAvailableAtCollege of Behavioral & Social Sciencesen_us
dc.relation.isAvailableAtPsychologyen_us
dc.relation.isAvailableAtDigital Repository at the University of Marylanden_us
dc.relation.isAvailableAtUniversity of Maryland (College Park, MD)en_us


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record